Mast cells mediate neutrophil recruitment during atherosclerotic plaque progression

Activated mast cells have been identified in the intima and perivascular tissue of human atherosclerotic plaques. As mast cells have been described to release a number of chemokines that mediate leukocyte fluxes, we propose that activated mast cells may play a pivotal role in leukocyte recruitment d...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Atherosclerosis Ročník 241; číslo 2; s. 289 - 296
Hlavní autoři: Wezel, Anouk, Lagraauw, H. Maxime, van der Velden, Daniël, de Jager, Saskia C.A., Quax, Paul H.A., Kuiper, Johan, Bot, Ilze
Médium: Journal Article
Jazyk:angličtina
Vydáno: Ireland Elsevier Ireland Ltd 01.08.2015
Témata:
ISSN:0021-9150, 1879-1484, 1879-1484
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Activated mast cells have been identified in the intima and perivascular tissue of human atherosclerotic plaques. As mast cells have been described to release a number of chemokines that mediate leukocyte fluxes, we propose that activated mast cells may play a pivotal role in leukocyte recruitment during atherosclerotic plaque progression. Systemic IgE-mediated mast cell activation in apoE−/−μMT mice resulted in an increase in atherosclerotic lesion size as compared to control mice, and interestingly, the number of neutrophils was highly increased in these lesions. In addition, peritoneal mast cell activation led to a massive neutrophil influx into the peritoneal cavity in C57Bl6 mice, whereas neutrophil numbers in mast cell deficient Kit(W-sh/W-sh) mice were not affected. Within the newly recruited neutrophil population, increased levels of CXCR2+ and CXCR4+ neutrophils were observed after mast cell activation. Indeed, mast cells were seen to contain and release CXCL1 and CXCL12, the ligands for CXCR2 and CXCR4. Intriguingly, peritoneal mast cell activation in combination with anti-CXCR2 receptor antagonist resulted in decreased neutrophil recruitment, thus establishing a prominent role for the CXCL1/CXCR2 axis in mast cell-mediated neutrophil recruitment. Our data suggest that chemokines, and in particular CXCL1, released from activated mast cells induce neutrophil recruitment to the site of inflammation, thereby aggravating the ongoing inflammatory response and thus affecting plaque progression and destabilization. •Systemic mast cell activation increased atherosclerotic plaque development.•Systemic mast cell activation induces neutrophil accumulation.•Peritoneal mast cell activation caused an influx of CXCR2+ and CXCR4+ neutrophils.•Mast cells express and secrete CXCL1 or CXCL12, the ligands for CXCR2 and CXCR4.•CXCR2 inhibition significantly reduced mast cell-mediated neutrophil recruitment.
AbstractList Abstract Aims Activated mast cells have been identified in the intima and perivascular tissue of human atherosclerotic plaques. As mast cells have been described to release a number of chemokines that mediate leukocyte fluxes, we propose that activated mast cells may play a pivotal role in leukocyte recruitment during atherosclerotic plaque progression. Methods and results Systemic IgE-mediated mast cell activation in apoE−/− μMT mice resulted in an increase in atherosclerotic lesion size as compared to control mice, and interestingly, the number of neutrophils was highly increased in these lesions. In addition, peritoneal mast cell activation led to a massive neutrophil influx into the peritoneal cavity in C57Bl6 mice, whereas neutrophil numbers in mast cell deficient Kit(W-sh /W-sh ) mice were not affected. Within the newly recruited neutrophil population, increased levels of CXCR2+ and CXCR4+ neutrophils were observed after mast cell activation. Indeed, mast cells were seen to contain and release CXCL1 and CXCL12, the ligands for CXCR2 and CXCR4. Intriguingly, peritoneal mast cell activation in combination with anti-CXCR2 receptor antagonist resulted in decreased neutrophil recruitment, thus establishing a prominent role for the CXCL1/CXCR2 axis in mast cell-mediated neutrophil recruitment. Conclusions Our data suggest that chemokines, and in particular CXCL1, released from activated mast cells induce neutrophil recruitment to the site of inflammation, thereby aggravating the ongoing inflammatory response and thus affecting plaque progression and destabilization.
Activated mast cells have been identified in the intima and perivascular tissue of human atherosclerotic plaques. As mast cells have been described to release a number of chemokines that mediate leukocyte fluxes, we propose that activated mast cells may play a pivotal role in leukocyte recruitment during atherosclerotic plaque progression.AIMSActivated mast cells have been identified in the intima and perivascular tissue of human atherosclerotic plaques. As mast cells have been described to release a number of chemokines that mediate leukocyte fluxes, we propose that activated mast cells may play a pivotal role in leukocyte recruitment during atherosclerotic plaque progression.Systemic IgE-mediated mast cell activation in apoE(-/-)μMT mice resulted in an increase in atherosclerotic lesion size as compared to control mice, and interestingly, the number of neutrophils was highly increased in these lesions. In addition, peritoneal mast cell activation led to a massive neutrophil influx into the peritoneal cavity in C57Bl6 mice, whereas neutrophil numbers in mast cell deficient Kit(W(-sh)/W(-sh)) mice were not affected. Within the newly recruited neutrophil population, increased levels of CXCR2(+) and CXCR4(+) neutrophils were observed after mast cell activation. Indeed, mast cells were seen to contain and release CXCL1 and CXCL12, the ligands for CXCR2 and CXCR4. Intriguingly, peritoneal mast cell activation in combination with anti-CXCR2 receptor antagonist resulted in decreased neutrophil recruitment, thus establishing a prominent role for the CXCL1/CXCR2 axis in mast cell-mediated neutrophil recruitment.METHODS AND RESULTSSystemic IgE-mediated mast cell activation in apoE(-/-)μMT mice resulted in an increase in atherosclerotic lesion size as compared to control mice, and interestingly, the number of neutrophils was highly increased in these lesions. In addition, peritoneal mast cell activation led to a massive neutrophil influx into the peritoneal cavity in C57Bl6 mice, whereas neutrophil numbers in mast cell deficient Kit(W(-sh)/W(-sh)) mice were not affected. Within the newly recruited neutrophil population, increased levels of CXCR2(+) and CXCR4(+) neutrophils were observed after mast cell activation. Indeed, mast cells were seen to contain and release CXCL1 and CXCL12, the ligands for CXCR2 and CXCR4. Intriguingly, peritoneal mast cell activation in combination with anti-CXCR2 receptor antagonist resulted in decreased neutrophil recruitment, thus establishing a prominent role for the CXCL1/CXCR2 axis in mast cell-mediated neutrophil recruitment.Our data suggest that chemokines, and in particular CXCL1, released from activated mast cells induce neutrophil recruitment to the site of inflammation, thereby aggravating the ongoing inflammatory response and thus affecting plaque progression and destabilization.CONCLUSIONSOur data suggest that chemokines, and in particular CXCL1, released from activated mast cells induce neutrophil recruitment to the site of inflammation, thereby aggravating the ongoing inflammatory response and thus affecting plaque progression and destabilization.
Activated mast cells have been identified in the intima and perivascular tissue of human atherosclerotic plaques. As mast cells have been described to release a number of chemokines that mediate leukocyte fluxes, we propose that activated mast cells may play a pivotal role in leukocyte recruitment during atherosclerotic plaque progression. Systemic IgE-mediated mast cell activation in apoE−/−μMT mice resulted in an increase in atherosclerotic lesion size as compared to control mice, and interestingly, the number of neutrophils was highly increased in these lesions. In addition, peritoneal mast cell activation led to a massive neutrophil influx into the peritoneal cavity in C57Bl6 mice, whereas neutrophil numbers in mast cell deficient Kit(W-sh/W-sh) mice were not affected. Within the newly recruited neutrophil population, increased levels of CXCR2+ and CXCR4+ neutrophils were observed after mast cell activation. Indeed, mast cells were seen to contain and release CXCL1 and CXCL12, the ligands for CXCR2 and CXCR4. Intriguingly, peritoneal mast cell activation in combination with anti-CXCR2 receptor antagonist resulted in decreased neutrophil recruitment, thus establishing a prominent role for the CXCL1/CXCR2 axis in mast cell-mediated neutrophil recruitment. Our data suggest that chemokines, and in particular CXCL1, released from activated mast cells induce neutrophil recruitment to the site of inflammation, thereby aggravating the ongoing inflammatory response and thus affecting plaque progression and destabilization. •Systemic mast cell activation increased atherosclerotic plaque development.•Systemic mast cell activation induces neutrophil accumulation.•Peritoneal mast cell activation caused an influx of CXCR2+ and CXCR4+ neutrophils.•Mast cells express and secrete CXCL1 or CXCL12, the ligands for CXCR2 and CXCR4.•CXCR2 inhibition significantly reduced mast cell-mediated neutrophil recruitment.
Activated mast cells have been identified in the intima and perivascular tissue of human atherosclerotic plaques. As mast cells have been described to release a number of chemokines that mediate leukocyte fluxes, we propose that activated mast cells may play a pivotal role in leukocyte recruitment during atherosclerotic plaque progression. Systemic IgE-mediated mast cell activation in apoE(-/-)μMT mice resulted in an increase in atherosclerotic lesion size as compared to control mice, and interestingly, the number of neutrophils was highly increased in these lesions. In addition, peritoneal mast cell activation led to a massive neutrophil influx into the peritoneal cavity in C57Bl6 mice, whereas neutrophil numbers in mast cell deficient Kit(W(-sh)/W(-sh)) mice were not affected. Within the newly recruited neutrophil population, increased levels of CXCR2(+) and CXCR4(+) neutrophils were observed after mast cell activation. Indeed, mast cells were seen to contain and release CXCL1 and CXCL12, the ligands for CXCR2 and CXCR4. Intriguingly, peritoneal mast cell activation in combination with anti-CXCR2 receptor antagonist resulted in decreased neutrophil recruitment, thus establishing a prominent role for the CXCL1/CXCR2 axis in mast cell-mediated neutrophil recruitment. Our data suggest that chemokines, and in particular CXCL1, released from activated mast cells induce neutrophil recruitment to the site of inflammation, thereby aggravating the ongoing inflammatory response and thus affecting plaque progression and destabilization.
Author de Jager, Saskia C.A.
Kuiper, Johan
Quax, Paul H.A.
van der Velden, Daniël
Lagraauw, H. Maxime
Wezel, Anouk
Bot, Ilze
Author_xml – sequence: 1
  givenname: Anouk
  surname: Wezel
  fullname: Wezel, Anouk
  organization: Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands
– sequence: 2
  givenname: H. Maxime
  surname: Lagraauw
  fullname: Lagraauw, H. Maxime
  organization: Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands
– sequence: 3
  givenname: Daniël
  surname: van der Velden
  fullname: van der Velden, Daniël
  organization: Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands
– sequence: 4
  givenname: Saskia C.A.
  surname: de Jager
  fullname: de Jager, Saskia C.A.
  organization: Laboratory of Experimental Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands
– sequence: 5
  givenname: Paul H.A.
  surname: Quax
  fullname: Quax, Paul H.A.
  organization: Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands
– sequence: 6
  givenname: Johan
  surname: Kuiper
  fullname: Kuiper, Johan
  organization: Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands
– sequence: 7
  givenname: Ilze
  surname: Bot
  fullname: Bot, Ilze
  email: i.bot@lacdr.leidenuniv.nl
  organization: Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26062988$$D View this record in MEDLINE/PubMed
BookMark eNqVUsFq3DAQFSUl2aT5heJLoRdvR7Jsy4cWypKmhZQe0p6FdjxOtNXKW0kO5O8rdxMoC4EEhtHlzZv33uiUHfnRE2PvOCw58ObDZmnSLYUxopu7jUsBvF5CLqFesQVXbVdyqeQRWwAIXna8hhN2GuMGAGTL1TE7EQ00olNqwa6_m5gKJOdisaXemkSFpymFcXdrXREIw2TTlnwq-ilYf1P8vz5ZLHbO_Jmo2IXxJlCMdvRv2OvBuEjnD-8Z-_Xl4ufqa3n14_Lb6vNViXUrUil7jiarrbnhMKgqa2uJ-qFpYTAKZYPGdJWQ0uSGlVibYaibNSGKVlY1Vmfs_Z43784SYtJbG2crxtM4Rc2bTkEFolUZ-vYBOq2zTb0LdmvCvX4MIgNWewBmbzHQoNEmk7KbFIx1moOe49cbfRC_nuPXkEvMLB8PWB4XPXf-cj9PObY7S0FHtOQxHyZfIul-tM9m-nTAhM56i8b9pnuKm3EKPt9Gcx2FBn09f5X5p8xVyX8EF08TvEDIXy513DE
CitedBy_id crossref_primary_10_3389_fcvm_2022_864602
crossref_primary_10_1007_s11883_024_01206_6
crossref_primary_10_1016_j_ygeno_2025_111013
crossref_primary_10_1111_all_13790
crossref_primary_10_1016_j_ejphar_2017_10_013
crossref_primary_10_1093_cvr_cvab285
crossref_primary_10_1007_s00011_024_01877_6
crossref_primary_10_3390_jpm13071116
crossref_primary_10_1038_nrcardio_2015_117
crossref_primary_10_1161_ATVBAHA_119_313744
crossref_primary_10_1177_03946320221092188
crossref_primary_10_3389_fmed_2023_1213320
crossref_primary_10_1007_s12016_024_08981_9
crossref_primary_10_1161_ATVBAHA_124_319843
crossref_primary_10_3390_cells9122538
crossref_primary_10_3390_ijms20184479
crossref_primary_10_1161_CIRCRESAHA_116_309606
crossref_primary_10_3389_fncel_2018_00072
crossref_primary_10_1007_s11883_020_00837_9
crossref_primary_10_1016_j_immuni_2020_12_017
crossref_primary_10_3389_fnins_2023_1277399
crossref_primary_10_3389_fphar_2019_01276
crossref_primary_10_1038_s41569_024_01016_y
crossref_primary_10_1159_000488091
crossref_primary_10_1002_JLB_4HI1018_390R
crossref_primary_10_3390_ijms22052529
crossref_primary_10_5551_jat_65460
crossref_primary_10_1111_aji_13002
crossref_primary_10_1177_0022034516634630
crossref_primary_10_1016_j_neuron_2019_01_012
crossref_primary_10_1002_jat_4699
crossref_primary_10_3390_ijms20143395
crossref_primary_10_3390_ijms24010205
crossref_primary_10_1093_postmj_qgae017
crossref_primary_10_3389_fcimb_2019_00322
crossref_primary_10_1016_j_celrep_2025_115909
crossref_primary_10_1111_all_15426
crossref_primary_10_3389_fcvm_2023_1174081
crossref_primary_10_3390_cells9030701
crossref_primary_10_1016_j_vph_2023_107172
crossref_primary_10_1111_imm_13849
crossref_primary_10_7717_peerj_1192
crossref_primary_10_3389_fphar_2023_1252907
crossref_primary_10_1038_s41569_018_0106_9
crossref_primary_10_1016_j_jaci_2018_10_054
crossref_primary_10_3389_fcvm_2025_1526170
crossref_primary_10_15212_CVIA_2025_0014
Cites_doi 10.1161/01.CIR.101.14.1665
10.1189/jlb.72.6.1122
10.1016/j.atherosclerosis.2010.11.024
10.1161/01.ATV.21.4.516
10.4049/jimmunol.182.1.647
10.2353/ajpath.2010.090480
10.1016/j.jaut.2012.11.003
10.1093/eurheartj/eht186
10.1038/nri2415
10.1093/cvr/cvq260
10.1038/350423a0
10.1161/CIRCULATIONAHA.110.961714
10.1016/j.immuni.2013.06.009
10.1001/archinte.158.13.1434
10.1002/jcp.10235
10.1016/j.yjmcc.2014.04.021
10.1161/ATVBAHA.113.301627
10.1016/S0140-6736(12)61689-4
10.1189/jlb.0703340
10.1371/journal.pone.0014525
10.1182/blood-2013-02-486217
10.1161/ATVBAHA.110.209296
10.1161/01.CIR.92.5.1084
10.1177/002215549704500703
10.1194/jlr.M032862
10.1038/ni.f.216
10.4049/jimmunol.1000033
10.1371/journal.pone.0017314
10.1016/S0140-6736(12)60367-5
10.1016/j.atherosclerosis.2006.12.016
10.1161/CIRCRESAHA.109.204875
10.1161/CIRCRESAHA.111.257535
10.1038/nm1601
10.1161/01.CIR.90.4.1669
10.1016/0003-2697(87)90021-2
10.1161/CIRCRESAHA.107.160697
10.1161/ATVBAHA.112.300857
10.1161/CIRCULATIONAHA.106.660472
10.1093/cvr/cvs312
ContentType Journal Article
Copyright 2015 Elsevier Ireland Ltd
Elsevier Ireland Ltd
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
Copyright_xml – notice: 2015 Elsevier Ireland Ltd
– notice: Elsevier Ireland Ltd
– notice: Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.atherosclerosis.2015.05.028
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic

MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1879-1484
EndPage 296
ExternalDocumentID 26062988
10_1016_j_atherosclerosis_2015_05_028
S0021915015013428
1_s2_0_S0021915015013428
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
23N
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AABNK
AAEDT
AAEDW
AAFWJ
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABJNI
ABLJU
ABMAC
ABMZM
ABOCM
ABXDB
ACDAQ
ACGFS
ACIEU
ACIUM
ACLOT
ACRLP
ACVFH
ADBBV
ADCNI
ADEZE
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AEXQZ
AFFNX
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CS3
EBS
EFJIC
EFKBS
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEB
HMK
HMO
HVGLF
HZ~
IHE
J1W
J5H
K-O
KOM
L7B
M27
M41
MO0
N9A
O-L
O9-
OAUVE
OA~
OK1
OL0
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SPCBC
SSH
SSZ
T5K
WUQ
X7M
Z5R
ZGI
ZXP
~G-
~HD
~KM
AACTN
AFCTW
AFKWA
AJOXV
AMFUW
NCXOZ
RIG
0SF
AAIAV
ABLVK
ABYKQ
AHPSJ
AJBFU
LCYCR
ZA5
9DU
AAYXX
CITATION
AGCQF
AGRNS
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c572t-4d1ca87951a10f834717eedf670fa8c46caa93244a324c32baff56becc27435c3
ISICitedReferencesCount 54
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000360100700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0021-9150
1879-1484
IngestDate Sun Sep 28 09:46:40 EDT 2025
Mon Jul 21 05:59:21 EDT 2025
Sat Nov 29 06:16:05 EST 2025
Tue Nov 18 22:36:17 EST 2025
Fri Feb 23 02:24:03 EST 2024
Sun Feb 23 10:19:14 EST 2025
Tue Oct 14 19:31:33 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Atherosclerotic plaque development and progression
Influx
Mast cells
Chemokines
Neutrophils
Recruitment
Language English
License Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c572t-4d1ca87951a10f834717eedf670fa8c46caa93244a324c32baff56becc27435c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 26062988
PQID 1698030278
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_1698030278
pubmed_primary_26062988
crossref_citationtrail_10_1016_j_atherosclerosis_2015_05_028
crossref_primary_10_1016_j_atherosclerosis_2015_05_028
elsevier_sciencedirect_doi_10_1016_j_atherosclerosis_2015_05_028
elsevier_clinicalkeyesjournals_1_s2_0_S0021915015013428
elsevier_clinicalkey_doi_10_1016_j_atherosclerosis_2015_05_028
PublicationCentury 2000
PublicationDate 2015-08-01
PublicationDateYYYYMMDD 2015-08-01
PublicationDate_xml – month: 08
  year: 2015
  text: 2015-08-01
  day: 01
PublicationDecade 2010
PublicationPlace Ireland
PublicationPlace_xml – name: Ireland
PublicationTitle Atherosclerosis
PublicationTitleAlternate Atherosclerosis
PublicationYear 2015
Publisher Elsevier Ireland Ltd
Publisher_xml – name: Elsevier Ireland Ltd
References Grützkau, Krüger-Krasagakes, Kögel, Möller, Lippert, Henz (bib28) 1997; 45
Willems, Vink, Bot, Quax, de Borst, de Vries (bib9) 2013; 34
Kovanen, Kaartinen, Paavonen (bib8) 1995; 92
Ionita, van den Borne, Catanzariti, Moll, de Vries, Pasterkamp (bib37) 2010; 30
Borissoff, Joosen, Versteylen, Brill, Fuchs, Savchenko (bib38) 2013; 33
Bot, Daissormont, Zernecke, van Puijvelde, Kramp, de Jager (bib30) 2014; 74
Kyaw, Tay, Khan, Dumouchel, Cao, To (bib22) 2010; 1950
Kovanen, Mänttäri, Palosuo, Manninen, Aho (bib10) 1998; 158
Rotzius, Thams, Soehnlein, Kenne, Tseng, Björkström (bib36) 2010; 177
Kaartinen, Penttilä, Kovanen (bib7) 1994; 90
Bot, de Jager, Zernecke, Lindstedt, van Berkel, Weber (bib5) 2007; 115
Kalesnikoff, Galli (bib17) 2008; 9
Bot, Bot, van Heiningen, van Santbrink, Lankhuizen, Hartman (bib18) 2011; 89
Leskinen, Wang, Leszczynski, Lindstedt, Kovanen (bib19) 2001; 21
Schramm, Schaefer, Menger, Thorlacius (bib33) 2002; 72
Hasenberg, Köhler, Bonifatius, Borucki, Riek-Burchardt, Achilles (bib23) 2011; 6
Zernecke, Bot, Djalali-Talab, Shagdarsuren, Bidzhekov, Meiler (bib29) 2008; 102
Christy, Walker, Hessner, Brown (bib32) 2013; 42
Sun, Sukhova, Wolters, Yang, Kitamoto, Libby (bib6) 2007; 13
Murray, Vos, Lozano, Naghavi, Flaxman, Michaud (bib1) 2012; 380
Bot, de Jager, MacAleese, Lagraauw, van Berkel, Quax (bib16) 2013; 54
Oksjoki, Laine, Helske, Vehmaan-Kreula, Mäyränpää, Gasque (bib11) 2007; 195
Lätti, Leskinen, Shiota, Wang, Kovanen, Lindstedt (bib20) 2003; 195
Soehnlein (bib39) 2012; 110
Bot, de Jager, Bot, van Heiningen, de Groot, Veldhuizen (bib14) 2010; 106
de Vries, Wezel, Schepers, van Santbrink, Woodruff, Niessen (bib12) 2013; 97
Shin, Nigrovic, Crish, Boilard, McNeil, Larabee (bib34) 2009; 1950
Weber, Zernecke, Libby (bib2) 2008; 8
Chomczynski, Sacchi (bib26) 1987; 162
Mihaylova, Emberson, Blackwell, Keech, Simes (bib4) 2012; 380
Laine, Naukkarinen, Heikkilä, Penttilä, Kovanen (bib13) 2000; 101
Libby, Lichtman, Hansson (bib3) 2013; 38
Boxio, Bossenmeyer-Pourié, Steinckwich, Dournon, Nüße (bib24) 2004; 75
Drechsler, Megens, van Zandvoort, Weber, Soehnlein (bib35) 2010; 122
de Jager, Bot, Kraaijeveld, Korporaal, Bot, van Santbrink (bib25) 2013; 33
Kitamura, Roes, Kühn, Rajewsky (bib21) 1991; 350
De Filippo, Dudeck, Hasenberg, Nye, van Rooijen, Hartmann (bib31) 2013; 121
Zhang, Alcaide, Liu, Sun, He, Luscinskas (bib27) 2011; 6
Lappalainen, Lindstedt, Oksjoki, Kovanen (bib15) 2011; 214
Boxio (10.1016/j.atherosclerosis.2015.05.028_bib24) 2004; 75
Shin (10.1016/j.atherosclerosis.2015.05.028_bib34) 2009; 1950
Lappalainen (10.1016/j.atherosclerosis.2015.05.028_bib15) 2011; 214
Bot (10.1016/j.atherosclerosis.2015.05.028_bib16) 2013; 54
Libby (10.1016/j.atherosclerosis.2015.05.028_bib3) 2013; 38
Sun (10.1016/j.atherosclerosis.2015.05.028_bib6) 2007; 13
Zhang (10.1016/j.atherosclerosis.2015.05.028_bib27) 2011; 6
Bot (10.1016/j.atherosclerosis.2015.05.028_bib5) 2007; 115
Chomczynski (10.1016/j.atherosclerosis.2015.05.028_bib26) 1987; 162
Borissoff (10.1016/j.atherosclerosis.2015.05.028_bib38) 2013; 33
Bot (10.1016/j.atherosclerosis.2015.05.028_bib14) 2010; 106
Kyaw (10.1016/j.atherosclerosis.2015.05.028_bib22) 2010; 1950
Bot (10.1016/j.atherosclerosis.2015.05.028_bib18) 2011; 89
Drechsler (10.1016/j.atherosclerosis.2015.05.028_bib35) 2010; 122
Zernecke (10.1016/j.atherosclerosis.2015.05.028_bib29) 2008; 102
Bot (10.1016/j.atherosclerosis.2015.05.028_bib30) 2014; 74
Murray (10.1016/j.atherosclerosis.2015.05.028_bib1) 2012; 380
Laine (10.1016/j.atherosclerosis.2015.05.028_bib13) 2000; 101
de Vries (10.1016/j.atherosclerosis.2015.05.028_bib12) 2013; 97
Schramm (10.1016/j.atherosclerosis.2015.05.028_bib33) 2002; 72
De Filippo (10.1016/j.atherosclerosis.2015.05.028_bib31) 2013; 121
Kitamura (10.1016/j.atherosclerosis.2015.05.028_bib21) 1991; 350
Rotzius (10.1016/j.atherosclerosis.2015.05.028_bib36) 2010; 177
Ionita (10.1016/j.atherosclerosis.2015.05.028_bib37) 2010; 30
Weber (10.1016/j.atherosclerosis.2015.05.028_bib2) 2008; 8
Leskinen (10.1016/j.atherosclerosis.2015.05.028_bib19) 2001; 21
Soehnlein (10.1016/j.atherosclerosis.2015.05.028_bib39) 2012; 110
Grützkau (10.1016/j.atherosclerosis.2015.05.028_bib28) 1997; 45
Kovanen (10.1016/j.atherosclerosis.2015.05.028_bib8) 1995; 92
Kovanen (10.1016/j.atherosclerosis.2015.05.028_bib10) 1998; 158
Lätti (10.1016/j.atherosclerosis.2015.05.028_bib20) 2003; 195
Kalesnikoff (10.1016/j.atherosclerosis.2015.05.028_bib17) 2008; 9
Willems (10.1016/j.atherosclerosis.2015.05.028_bib9) 2013; 34
Oksjoki (10.1016/j.atherosclerosis.2015.05.028_bib11) 2007; 195
Kaartinen (10.1016/j.atherosclerosis.2015.05.028_bib7) 1994; 90
de Jager (10.1016/j.atherosclerosis.2015.05.028_bib25) 2013; 33
Christy (10.1016/j.atherosclerosis.2015.05.028_bib32) 2013; 42
Hasenberg (10.1016/j.atherosclerosis.2015.05.028_bib23) 2011; 6
Mihaylova (10.1016/j.atherosclerosis.2015.05.028_bib4) 2012; 380
References_xml – volume: 75
  start-page: 604
  year: 2004
  end-page: 611
  ident: bib24
  article-title: Mouse bone marrow contains large numbers of functionally competent neutrophils
  publication-title: J. Leukoc. Biol.
– volume: 106
  start-page: 89
  year: 2010
  end-page: 92
  ident: bib14
  article-title: The neuropeptide substance P mediates adventitial mast cell activation and induces intraplaque hemorrhage in advanced atherosclerosis
  publication-title: Circ. Res.
– volume: 110
  start-page: 875
  year: 2012
  end-page: 888
  ident: bib39
  article-title: Multiple roles for neutrophils in atherosclerosis
  publication-title: Circ. Res.
– volume: 158
  start-page: 1434
  year: 1998
  end-page: 1439
  ident: bib10
  article-title: Prediction of myocardial infarction in dyslipidemic men by elevated levels of immunoglobulin classes A, E, and G, but not M
  publication-title: Arch. Intern. Med.
– volume: 38
  start-page: 1092
  year: 2013
  end-page: 1104
  ident: bib3
  article-title: Immune effector mechanisms implicated in atherosclerosis: from mice to humans
  publication-title: Immunity
– volume: 72
  start-page: 1122
  year: 2002
  end-page: 1132
  ident: bib33
  article-title: Acute mast cell-dependent neutrophil recruitment in the skin is mediated by KC and LFA-1: inhibitory mechanisms of dexamethasone
  publication-title: J. Leukoc. Biol.
– volume: 195
  start-page: 90
  year: 2007
  end-page: 99
  ident: bib11
  article-title: Receptors for the anaphylatoxins C3a and C5a are expressed in human atherosclerotic coronary plaques
  publication-title: Atherosclerosis
– volume: 195
  start-page: 130
  year: 2003
  end-page: 138
  ident: bib20
  article-title: Mast cell-mediated apoptosis of endothelial cells
  publication-title: J. Cell. Physiol.
– volume: 350
  start-page: 423
  year: 1991
  end-page: 426
  ident: bib21
  article-title: A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene
  publication-title: Nature
– volume: 6
  start-page: e14525
  year: 2011
  ident: bib27
  article-title: Regulation of endothelial cell adhesion molecule expression by mast cells, macrophages, and neutrophils
  publication-title: PLoS One
– volume: 42
  start-page: 50
  year: 2013
  end-page: 61
  ident: bib32
  article-title: Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE
  publication-title: J. Autoimmun.
– volume: 1950
  start-page: 647
  year: 2009
  end-page: 656
  ident: bib34
  article-title: Mast cells contribute to autoimmune inflammatory arthritis via their tryptase/heparin complexes
  publication-title: J. Immunol. Balt. Md.
– volume: 90
  start-page: 1669
  year: 1994
  end-page: 1678
  ident: bib7
  article-title: Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture
  publication-title: Circulation
– volume: 74
  start-page: 44
  year: 2014
  end-page: 52
  ident: bib30
  article-title: CXCR4 blockade induces atherosclerosis by affecting neutrophil function
  publication-title: J. Mol. Cell. Cardiol.
– volume: 45
  start-page: 935
  year: 1997
  end-page: 945
  ident: bib28
  article-title: Detection of intracellular interleukin-8 in human mast cells: flow cytometry as a guide for immunoelectron microscopy
  publication-title: J. Histochem. Cytochem. Off. J. Histochem. Soc.
– volume: 97
  start-page: 311
  year: 2013
  end-page: 320
  ident: bib12
  article-title: Complement factor C5a as mast cell activator mediates vascular remodelling in vein graft disease
  publication-title: Cardiovasc. Res.
– volume: 33
  start-page: e75
  year: 2013
  end-page: 83
  ident: bib25
  article-title: Leukocyte-specific CCL3 deficiency inhibits atherosclerotic lesion development by affecting neutrophil accumulation
  publication-title: Arterioscler. Thromb. Vasc. Biol.
– volume: 13
  start-page: 719
  year: 2007
  end-page: 724
  ident: bib6
  article-title: Mast cells promote atherosclerosis by releasing proinflammatory cytokines
  publication-title: Nat. Med.
– volume: 380
  start-page: 581
  year: 2012
  end-page: 590
  ident: bib4
  article-title: The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
  publication-title: Lancet
– volume: 101
  start-page: 1665
  year: 2000
  end-page: 1669
  ident: bib13
  article-title: Adventitial mast cells connect with sensory nerve fibers in atherosclerotic coronary arteries
  publication-title: Circulation
– volume: 6
  start-page: e17314
  year: 2011
  ident: bib23
  article-title: Rapid immunomagnetic negative enrichment of neutrophil granulocytes from murine bone marrow for functional studies
  publication-title: PLoS One
– volume: 162
  start-page: 156
  year: 1987
  end-page: 159
  ident: bib26
  article-title: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
  publication-title: Anal. Biochem.
– volume: 122
  start-page: 1837
  year: 2010
  end-page: 1845
  ident: bib35
  article-title: Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis
  publication-title: Circulation
– volume: 177
  start-page: 493
  year: 2010
  end-page: 500
  ident: bib36
  article-title: Distinct infiltration of neutrophils in lesion shoulders in apoE
  publication-title: Am. J. Pathol.
– volume: 21
  start-page: 516
  year: 2001
  end-page: 522
  ident: bib19
  article-title: Mast cell chymase induces apoptosis of vascular smooth muscle cells
  publication-title: Arterioscler. Thromb. Vasc. Biol.
– volume: 115
  start-page: 2516
  year: 2007
  end-page: 2525
  ident: bib5
  article-title: Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice
  publication-title: Circulation
– volume: 34
  start-page: 3699
  year: 2013
  end-page: 3706
  ident: bib9
  article-title: Mast cells in human carotid atherosclerotic plaques are associated with intraplaque microvessel density and the occurrence of future cardiovascular events
  publication-title: Eur. Heart J.
– volume: 33
  start-page: 2032
  year: 2013
  end-page: 2040
  ident: bib38
  article-title: Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state
  publication-title: Arterioscler. Thromb. Vasc. Biol.
– volume: 9
  start-page: 1215
  year: 2008
  end-page: 1223
  ident: bib17
  article-title: New developments in mast cell biology
  publication-title: Nat. Immunol.
– volume: 214
  start-page: 357
  year: 2011
  end-page: 363
  ident: bib15
  article-title: OxLDL-IgG immune complexes induce expression and secretion of proatherogenic cytokines by cultured human mast cells
  publication-title: Atherosclerosis
– volume: 380
  start-page: 2197
  year: 2012
  end-page: 2223
  ident: bib1
  article-title: Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
  publication-title: Lancet
– volume: 89
  start-page: 244
  year: 2011
  end-page: 252
  ident: bib18
  article-title: Mast cell chymase inhibition reduces atherosclerotic plaque progression and improves plaque stability in apoE
  publication-title: Cardiovasc. Res.
– volume: 30
  start-page: 1842
  year: 2010
  end-page: 1848
  ident: bib37
  article-title: High neutrophil numbers in human carotid atherosclerotic plaques are associated with characteristics of rupture-prone lesions
  publication-title: Arterioscler. Thromb. Vasc. Biol.
– volume: 121
  start-page: 4930
  year: 2013
  end-page: 4937
  ident: bib31
  article-title: Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation
  publication-title: Blood
– volume: 54
  start-page: 1265
  year: 2013
  end-page: 1274
  ident: bib16
  article-title: Lysophosphatidic acid triggers mast cell-driven atherosclerotic plaque destabilization by increasing vascular inflammation
  publication-title: J. Lipid Res.
– volume: 92
  start-page: 1084
  year: 1995
  end-page: 1088
  ident: bib8
  article-title: Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction
  publication-title: Circulation
– volume: 102
  start-page: 209
  year: 2008
  end-page: 217
  ident: bib29
  article-title: Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis
  publication-title: Circ. Res.
– volume: 8
  start-page: 802
  year: 2008
  end-page: 815
  ident: bib2
  article-title: The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models
  publication-title: Nat. Rev. Immunol.
– volume: 1950
  start-page: 4410
  year: 2010
  end-page: 4419
  ident: bib22
  article-title: Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis
  publication-title: J. Immunol. Balt. Md.
– volume: 101
  start-page: 1665
  year: 2000
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib13
  article-title: Adventitial mast cells connect with sensory nerve fibers in atherosclerotic coronary arteries
  publication-title: Circulation
  doi: 10.1161/01.CIR.101.14.1665
– volume: 72
  start-page: 1122
  year: 2002
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib33
  article-title: Acute mast cell-dependent neutrophil recruitment in the skin is mediated by KC and LFA-1: inhibitory mechanisms of dexamethasone
  publication-title: J. Leukoc. Biol.
  doi: 10.1189/jlb.72.6.1122
– volume: 214
  start-page: 357
  year: 2011
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib15
  article-title: OxLDL-IgG immune complexes induce expression and secretion of proatherogenic cytokines by cultured human mast cells
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2010.11.024
– volume: 21
  start-page: 516
  year: 2001
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib19
  article-title: Mast cell chymase induces apoptosis of vascular smooth muscle cells
  publication-title: Arterioscler. Thromb. Vasc. Biol.
  doi: 10.1161/01.ATV.21.4.516
– volume: 1950
  start-page: 647
  issue: 182
  year: 2009
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib34
  article-title: Mast cells contribute to autoimmune inflammatory arthritis via their tryptase/heparin complexes
  publication-title: J. Immunol. Balt. Md.
  doi: 10.4049/jimmunol.182.1.647
– volume: 177
  start-page: 493
  year: 2010
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib36
  article-title: Distinct infiltration of neutrophils in lesion shoulders in apoE−/− mice
  publication-title: Am. J. Pathol.
  doi: 10.2353/ajpath.2010.090480
– volume: 42
  start-page: 50
  year: 2013
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib32
  article-title: Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE
  publication-title: J. Autoimmun.
  doi: 10.1016/j.jaut.2012.11.003
– volume: 34
  start-page: 3699
  year: 2013
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib9
  article-title: Mast cells in human carotid atherosclerotic plaques are associated with intraplaque microvessel density and the occurrence of future cardiovascular events
  publication-title: Eur. Heart J.
  doi: 10.1093/eurheartj/eht186
– volume: 8
  start-page: 802
  year: 2008
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib2
  article-title: The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri2415
– volume: 89
  start-page: 244
  year: 2011
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib18
  article-title: Mast cell chymase inhibition reduces atherosclerotic plaque progression and improves plaque stability in apoE−/− mice
  publication-title: Cardiovasc. Res.
  doi: 10.1093/cvr/cvq260
– volume: 350
  start-page: 423
  year: 1991
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib21
  article-title: A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene
  publication-title: Nature
  doi: 10.1038/350423a0
– volume: 122
  start-page: 1837
  year: 2010
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib35
  article-title: Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.110.961714
– volume: 38
  start-page: 1092
  year: 2013
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib3
  article-title: Immune effector mechanisms implicated in atherosclerosis: from mice to humans
  publication-title: Immunity
  doi: 10.1016/j.immuni.2013.06.009
– volume: 158
  start-page: 1434
  year: 1998
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib10
  article-title: Prediction of myocardial infarction in dyslipidemic men by elevated levels of immunoglobulin classes A, E, and G, but not M
  publication-title: Arch. Intern. Med.
  doi: 10.1001/archinte.158.13.1434
– volume: 195
  start-page: 130
  year: 2003
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib20
  article-title: Mast cell-mediated apoptosis of endothelial cells in vitro: a paracrine mechanism involving TNF-alpha-mediated down-regulation of bcl-2 expression
  publication-title: J. Cell. Physiol.
  doi: 10.1002/jcp.10235
– volume: 74
  start-page: 44
  year: 2014
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib30
  article-title: CXCR4 blockade induces atherosclerosis by affecting neutrophil function
  publication-title: J. Mol. Cell. Cardiol.
  doi: 10.1016/j.yjmcc.2014.04.021
– volume: 33
  start-page: 2032
  year: 2013
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib38
  article-title: Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state
  publication-title: Arterioscler. Thromb. Vasc. Biol.
  doi: 10.1161/ATVBAHA.113.301627
– volume: 380
  start-page: 2197
  year: 2012
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib1
  article-title: Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
  publication-title: Lancet
  doi: 10.1016/S0140-6736(12)61689-4
– volume: 75
  start-page: 604
  year: 2004
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib24
  article-title: Mouse bone marrow contains large numbers of functionally competent neutrophils
  publication-title: J. Leukoc. Biol.
  doi: 10.1189/jlb.0703340
– volume: 6
  start-page: e14525
  year: 2011
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib27
  article-title: Regulation of endothelial cell adhesion molecule expression by mast cells, macrophages, and neutrophils
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0014525
– volume: 121
  start-page: 4930
  year: 2013
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib31
  article-title: Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation
  publication-title: Blood
  doi: 10.1182/blood-2013-02-486217
– volume: 30
  start-page: 1842
  year: 2010
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib37
  article-title: High neutrophil numbers in human carotid atherosclerotic plaques are associated with characteristics of rupture-prone lesions
  publication-title: Arterioscler. Thromb. Vasc. Biol.
  doi: 10.1161/ATVBAHA.110.209296
– volume: 92
  start-page: 1084
  year: 1995
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib8
  article-title: Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction
  publication-title: Circulation
  doi: 10.1161/01.CIR.92.5.1084
– volume: 45
  start-page: 935
  year: 1997
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib28
  article-title: Detection of intracellular interleukin-8 in human mast cells: flow cytometry as a guide for immunoelectron microscopy
  publication-title: J. Histochem. Cytochem. Off. J. Histochem. Soc.
  doi: 10.1177/002215549704500703
– volume: 54
  start-page: 1265
  year: 2013
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib16
  article-title: Lysophosphatidic acid triggers mast cell-driven atherosclerotic plaque destabilization by increasing vascular inflammation
  publication-title: J. Lipid Res.
  doi: 10.1194/jlr.M032862
– volume: 9
  start-page: 1215
  year: 2008
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib17
  article-title: New developments in mast cell biology
  publication-title: Nat. Immunol.
  doi: 10.1038/ni.f.216
– volume: 1950
  start-page: 4410
  issue: 185
  year: 2010
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib22
  article-title: Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis
  publication-title: J. Immunol. Balt. Md.
  doi: 10.4049/jimmunol.1000033
– volume: 6
  start-page: e17314
  year: 2011
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib23
  article-title: Rapid immunomagnetic negative enrichment of neutrophil granulocytes from murine bone marrow for functional studies in vitro and in vivo
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0017314
– volume: 380
  start-page: 581
  year: 2012
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib4
  article-title: The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials
  publication-title: Lancet
  doi: 10.1016/S0140-6736(12)60367-5
– volume: 195
  start-page: 90
  year: 2007
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib11
  article-title: Receptors for the anaphylatoxins C3a and C5a are expressed in human atherosclerotic coronary plaques
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2006.12.016
– volume: 106
  start-page: 89
  year: 2010
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib14
  article-title: The neuropeptide substance P mediates adventitial mast cell activation and induces intraplaque hemorrhage in advanced atherosclerosis
  publication-title: Circ. Res.
  doi: 10.1161/CIRCRESAHA.109.204875
– volume: 110
  start-page: 875
  year: 2012
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib39
  article-title: Multiple roles for neutrophils in atherosclerosis
  publication-title: Circ. Res.
  doi: 10.1161/CIRCRESAHA.111.257535
– volume: 13
  start-page: 719
  year: 2007
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib6
  article-title: Mast cells promote atherosclerosis by releasing proinflammatory cytokines
  publication-title: Nat. Med.
  doi: 10.1038/nm1601
– volume: 90
  start-page: 1669
  year: 1994
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib7
  article-title: Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture
  publication-title: Circulation
  doi: 10.1161/01.CIR.90.4.1669
– volume: 162
  start-page: 156
  year: 1987
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib26
  article-title: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
  publication-title: Anal. Biochem.
  doi: 10.1016/0003-2697(87)90021-2
– volume: 102
  start-page: 209
  year: 2008
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib29
  article-title: Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis
  publication-title: Circ. Res.
  doi: 10.1161/CIRCRESAHA.107.160697
– volume: 33
  start-page: e75
  year: 2013
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib25
  article-title: Leukocyte-specific CCL3 deficiency inhibits atherosclerotic lesion development by affecting neutrophil accumulation
  publication-title: Arterioscler. Thromb. Vasc. Biol.
  doi: 10.1161/ATVBAHA.112.300857
– volume: 115
  start-page: 2516
  year: 2007
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib5
  article-title: Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.106.660472
– volume: 97
  start-page: 311
  year: 2013
  ident: 10.1016/j.atherosclerosis.2015.05.028_bib12
  article-title: Complement factor C5a as mast cell activator mediates vascular remodelling in vein graft disease
  publication-title: Cardiovasc. Res.
  doi: 10.1093/cvr/cvs312
SSID ssj0004718
Score 2.3864257
Snippet Activated mast cells have been identified in the intima and perivascular tissue of human atherosclerotic plaques. As mast cells have been described to release...
Abstract Aims Activated mast cells have been identified in the intima and perivascular tissue of human atherosclerotic plaques. As mast cells have been...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 289
SubjectTerms Animals
Aorta - immunology
Aorta - metabolism
Aorta - pathology
Aortic Diseases - genetics
Aortic Diseases - immunology
Aortic Diseases - metabolism
Aortic Diseases - pathology
Apolipoproteins E - deficiency
Apolipoproteins E - genetics
Atherosclerosis - genetics
Atherosclerosis - immunology
Atherosclerosis - metabolism
Atherosclerosis - pathology
Atherosclerotic plaque development and progression
Cardiovascular
Cells, Cultured
Chemokine CXCL1 - immunology
Chemokine CXCL1 - metabolism
Chemokine CXCL12 - immunology
Chemokine CXCL12 - metabolism
Chemokines
Disease Models, Animal
Disease Progression
Immunoglobulin E - administration & dosage
Immunoglobulin E - immunology
Influx
Male
Mast cells
Mast Cells - drug effects
Mast Cells - immunology
Mast Cells - pathology
Mice, Inbred C57BL
Mice, Knockout
Neutrophil Infiltration - drug effects
Neutrophils
Neutrophils - drug effects
Neutrophils - immunology
Neutrophils - metabolism
Paracrine Communication
Plaque, Atherosclerotic
Receptors, CXCR4 - immunology
Receptors, CXCR4 - metabolism
Receptors, Interleukin-8B - antagonists & inhibitors
Receptors, Interleukin-8B - immunology
Receptors, Interleukin-8B - metabolism
Recruitment
Signal Transduction
Title Mast cells mediate neutrophil recruitment during atherosclerotic plaque progression
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0021915015013428
https://www.clinicalkey.es/playcontent/1-s2.0-S0021915015013428
https://dx.doi.org/10.1016/j.atherosclerosis.2015.05.028
https://www.ncbi.nlm.nih.gov/pubmed/26062988
https://www.proquest.com/docview/1698030278
Volume 241
WOSCitedRecordID wos000360100700001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: ScienceDirect database
  customDbUrl:
  eissn: 1879-1484
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0004718
  issn: 0021-9150
  databaseCode: AIEXJ
  dateStart: 19950106
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ta9swEBZpO8q-jL2veykebJ-CgyW_SIYxlpWOtixlsG7LN6PI8pYus0PslLDftR-4u0h23HYdKWNgRDCWZOuenE7S3XOEvNCYuooq7fpRHLiB5syVKZeu9MMRg_VzypRaJpvgx8diOIw_dDq_6liYswnPc7FYxNP_Kmq4B8LG0NlriLtpFG7AbxA6lCB2KNcS_ECWVRf340sTFlLpbq7n1ayYfhsjib-azcfGtbwOUUQbsCihmVmB9K3TiURO16XnlmHtaFuw_dbT5bixyL_on_a8Py_mTfTPe_l1JuV8eXx00OsO5GL8o0ESRk4hk8VnPamVHyaYwpP7t43fR6q7R0izYXavy-9j2d3r9XvtzQoaNq5ydgetjqI5xEidPG25LpnIAgrK1xDR9rRRyILHLjV8p43GZoYry0KTtfWvyUdkp3JmkuVemiXMhsVpT54fMXT0C5c8rjZe_TwRN55rU3w9vHxYtm2QLcbDGHTpVv9wf3i0isfl1FgA9nu2ycuVX-FfOr3KNrpq7bO0gU5uk1t28eL0DejukI7O75LtgXXPuEc-IvacJfYciz1nhT2nhT3HYM-5gD3HYM9pYe8--fRu_2TvwLVZO1wVcla5QUqVxBT2VFIvEz4MBgdDLIu4l0mhgkhJCYuGIJBQKJ-NZJaFEaoSBtZsqPwHZDMvcv2IOFT7KedZMAqUCnQay1RoivxKo9SjIyF2yKt6vBJlKe0xs8okqX0XT5MLw53gcCceXAyqR031qeF2Wbfi61o4SR3ADFNuAvhatwH-pwZ0afVImdCkZImXXMLcDnnT1LQ2srF9r9P58xpPCcwlCAqZ62IOnUax8NCRAZ55aIDWDAyLvIjFQjz-9xd4Qm6udMNTslnN5voZuaHOqnE52yUbfCh27V_qNzX-Bnw
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mast+cells+mediate+neutrophil+recruitment+during+atherosclerotic+plaque+progression&rft.jtitle=Atherosclerosis&rft.au=Wezel%2C+Anouk&rft.au=Lagraauw%2C+H.+Maxime&rft.au=van+der+Velden%2C+Dani%C3%ABl&rft.au=de+Jager%2C+Saskia+C.A.&rft.date=2015-08-01&rft.pub=Elsevier+Ireland+Ltd&rft.issn=0021-9150&rft.eissn=1879-1484&rft.volume=241&rft.issue=2&rft.spage=289&rft.epage=296&rft_id=info:doi/10.1016%2Fj.atherosclerosis.2015.05.028&rft.externalDocID=S0021915015013428
thumbnail_m http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00219150%2FS0021915015X00062%2Fcov150h.gif